Dept. of Pharmacology, Physiology and Neuroscience, Univ. of South Carolina, Columbia, SC 29209, 8 Yaupon Way, Oak Island, NC 28465, United States.
J Crit Care. 2017 Dec;42:54-58. doi: 10.1016/j.jcrc.2017.06.025. Epub 2017 Jun 29.
This study addresses the clinically important relationship between the decreases in plasma Na and the increases in plasma glucose concentrations seen in diabetes and other hyperglycemic syndromes. This plasma 'Na correction factor', is generally accepted as 1.6mM Na per 100mg% glucose (0.29mM/mM in SI units) assuming osmotic equilibrium, although much larger numbers have been measured in experiments on normal humans. To resolve this controversy, a mathematical model of whole-body fluid-electrolyte balance was used to perform the experiment wherein plasma glucose concentration was increased to diabetic levels and the plasma Na concentration changes assessed, without the complications seen in human experiments. The findings, based on osmotic grounds, were that the factor 1) was significantly <1.6, approaching 1 in some cases, 2) depended upon the anthropometry of the subject; it was inversely proportional to the ratio of extracellular to total body water, which increases with higher fat content and 3) was approximately linear up to glucose concentrations of about 800mg%, but decreased up to 10% for higher glucose concentrations. To explain the experimental data, a hypothesis of Na sequestration in cells was incorporated in the model, resulting in close prediction of measured transient Na changes.
本研究探讨了在糖尿病和其他高血糖综合征中观察到的血浆 Na 降低与血浆葡萄糖浓度升高之间的临床重要关系。这个血浆“Na 校正因子”通常被认为是每 100mg%葡萄糖增加 1.6mM Na(在 SI 单位中为 0.29mM/mM),假设渗透平衡,尽管在正常人体实验中已经测量到更大的数值。为了解决这个争议,使用全身液-电解质平衡的数学模型来进行实验,其中将血浆葡萄糖浓度升高至糖尿病水平,并评估血浆 Na 浓度变化,而没有在人体实验中看到的并发症。基于渗透压的发现是,该因子 1)显著<1.6,在某些情况下接近 1,2)取决于受试者的人体测量学;它与细胞外液与总体水的比例成反比,随着脂肪含量的增加而增加,3)在葡萄糖浓度约为 800mg%时近似线性,但在更高的葡萄糖浓度下降低到 10%。为了解释实验数据,在模型中纳入了 Na 细胞内蓄积的假设,从而对测量的瞬态 Na 变化进行了密切预测。